Callan Family Office LLC bought a new stake in Relx Plc (NYSE:RELX – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 13,588 shares of the technology company’s stock, valued at approximately $617,000.
Several other institutional investors and hedge funds have also made changes to their positions in RELX. CENTRAL TRUST Co lifted its holdings in shares of Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after purchasing an additional 529 shares during the last quarter. Versant Capital Management Inc purchased a new stake in shares of Relx in the 4th quarter valued at about $31,000. Sierra Ocean LLC purchased a new stake in shares of Relx in the 4th quarter valued at about $43,000. Private Trust Co. NA lifted its holdings in shares of Relx by 119.9% in the 3rd quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after purchasing an additional 566 shares during the last quarter. Finally, Whipplewood Advisors LLC purchased a new stake in shares of Relx in the 4th quarter valued at about $74,000. 15.02% of the stock is owned by hedge funds and other institutional investors.
Relx Stock Up 1.8 %
RELX opened at $48.08 on Monday. The business has a 50 day moving average price of $48.62 and a two-hundred day moving average price of $47.55. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The company has a market cap of $89.36 billion, a PE ratio of 25.85, a P/E/G ratio of 2.73 and a beta of 0.90. Relx Plc has a 52 week low of $40.25 and a 52 week high of $51.99.
Relx Increases Dividend
Analyst Ratings Changes
Several research firms have recently weighed in on RELX. Redburn Atlantic began coverage on Relx in a report on Wednesday, January 8th. They issued a “buy” rating for the company. StockNews.com downgraded Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th.
Read Our Latest Report on Relx
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
- Five stocks we like better than Relx
- What is a Secondary Public Offering? What Investors Need to Know
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Conference Calls and Individual Investors
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- The 3 Best Fintech Stocks to Buy Now
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.